Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Special Issue Letter to the Editor

Preprocedural Surveillance Testing for SARS-CoV-2 in an Asymptomatic Population in the Seattle Region Shows Low Rates of Positivity

James A. Mays, Alexander L. Greninger, Keith R. Jerome, John B. Lynch, Patrick C. Mathias
Yi-Wei Tang, Editor
James A. Mays
aDepartment of Laboratory Medicine, University of Washington School of Medicine, Seattle, Washington, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James A. Mays
Alexander L. Greninger
aDepartment of Laboratory Medicine, University of Washington School of Medicine, Seattle, Washington, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keith R. Jerome
aDepartment of Laboratory Medicine, University of Washington School of Medicine, Seattle, Washington, USA
bVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John B. Lynch
cDivision of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick C. Mathias
aDepartment of Laboratory Medicine, University of Washington School of Medicine, Seattle, Washington, USA
dDepartment of Biomedical Informatics and Medical Education, University of Washington School of Medicine, Seattle, Washington, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patrick C. Mathias
Yi-Wei Tang
Cepheid
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.01193-20
  • Article
  • Info & Metrics
  • PDF
Loading

LETTER

Seattle-region hospitals have been impacted for several months by community spread of the coronavirus disease of 2019 (COVID-19) (1, 2). Although testing was initially focused on the diagnosis of symptomatic patients, this effort has now expanded to include surveillance of asymptomatic patients to protect health care workers and prevent nosocomial infections. There is an urgent need to understand best practices for the delivery of routine medical care during an ongoing outbreak (3). Here, we report rates of SARS-CoV-2 infection in asymptomatic patients screened prior to admission or a surgical or aerosol-generating procedure.

On 13 April 2020, our hospital system began universal surveillance screening of asymptomatic patients prior to admission (n = 1,269; 43.6% female; median age, 55 years; standard deviation [SD] = 20.2) and surgeries and aerosol-generating procedures (n = 787; 38% female; median age, 55 years; SD = 19.0). The testing indication was stated at the time of order. PCR testing was performed on nasopharyngeal swabs using the Washington State emergency use-authorized University of Washington CDC-based laboratory-developed test (n = 176) or FDA-authorized DiaSorin Simplexa SARS-CoV-2 (n = 1,241), Hologic Panther Fusion SARS-CoV-2 (n = 2,591), or Roche cobas SARS-CoV-2 tests (n = 423) (4). This study was approved by the Institutional Review Board of the University of Washington Medical Center under a consent waiver (STUDY00009734).

For patients undergoing procedures, 5 of 787 patients (0.6%) were positive for SARS-CoV-2. For patients who were asymptomatic and tested at the time of admission, 4 of 1,269 patients (0.3%) were positive, and 2 of 1,269 (0.2%) were inconclusive; inconclusive results were treated as low-level positives and retested until negative. Among these patients, 4/9 positive and 1/2 inconclusive patients were intubated, sedated, intoxicated, or cognitively impaired at the time of assessment. By comparison, among inpatients with concerning symptoms (n = 1,336; 38.6% female; median age, 53; SD = 18.7), 137 of 1,336 patients (10.3%) were positive, and 1 of 1,336 (0.07%) was inconclusive. Among asymptomatic patients tested for any other reason (e.g., exposure risk), 32 of 425 (7.5%) were positive, and 1 of 425 (0.2%) was inconclusive. During this time, the outpatient prevalence of SARS-CoV-2 active infection in our region was 2 to 5% (5).

The application in our region of universal testing for SARS-CoV-2 prior to surgery or aerosolizing procedures and hospital admissions shows that the positivity rate for SARS-CoV-2 is low (<1%) in asymptomatic patients without known exposure risk factors. This measure is notably lower than reported measurements during an outbreak in New York City that found a positivity rate of 13.7% in asymptomatic pregnant women (6). The rate of subclinical infection likely varies with the scale of the community outbreak.

Even during a community-wide outbreak in Seattle, our data show a low prevalence of COVID-19 infection in the preprocedural setting. These data provide an assessment of exposure risk around the time of admission in a population that uses medical services. The Greater Seattle Coronavirus Assessment Network (SCAN) also published results from 18 days of home-based testing and reported no positive tests in 1,392 patients reporting no COVID-19-like illness (7). Although other studies support a large proportion of asymptomatic infections, data from this metropolitan outbreak suggest a different pattern. Importantly, this universal surveillance testing decreased the use of personal protective equipment (PPE), identified appropriate precautions for patients, and reduced the risk of nosocomial infection in cases where infection was not suspected.

ACKNOWLEDGMENTS

A.L.G. discloses personal fees from Abbott Molecular Inc. outside the submitted work.

  • Copyright © 2020 American Society for Microbiology.

All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Holshue ML,
    2. DeBolt C,
    3. Lindquist S,
    4. Lofy KH,
    5. Wiesman J,
    6. Bruce H,
    7. Spitters C,
    8. Ericson K,
    9. Wilkerson S,
    10. Tural A,
    11. Diaz G,
    12. Cohn A,
    13. Fox L,
    14. Patel A,
    15. Gerber SI,
    16. Kim L,
    17. Tong S,
    18. Lu X,
    19. Lindstrom S,
    20. Pallansch MA,
    21. Weldon WC,
    22. Biggs HM,
    23. Uyeki TM,
    24. Pillai SK
    , Washington State 2019-nCoV Case Investigation Team. 2020. First case of 2019 novel coronavirus in the United States. N Engl J Med 382:929–936. doi:10.1056/NEJMoa2001191.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Bhatraju PK,
    2. Ghassemieh BJ,
    3. Nichols M,
    4. Kim R,
    5. Jerome KR,
    6. Nalla AK,
    7. Greninger AL,
    8. Pipavath S,
    9. Wurfel MM,
    10. Evans L,
    11. Kritek PA,
    12. West TE,
    13. Luks A,
    14. Gerbino A,
    15. Dale CR,
    16. Goldman JD,
    17. O'Mahony S,
    18. Mikacenic C
    . 2020. Covid-19 in critically ill patients in the Seattle region — case series. N Engl J Med 382:2012–2022. doi:10.1056/NEJMoa2004500.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Ueda M,
    2. Martins R,
    3. Hendrie PC,
    4. McDonnell T,
    5. Crews JR,
    6. Wong TL,
    7. McCreery B,
    8. Jagels B,
    9. Crane A,
    10. Byrd DR,
    11. Pergam SA,
    12. Davidson NE,
    13. Liu C,
    14. Stewart FM
    . 2020. Managing cancer care during the Covid-19 pandemic: agility and collaboration toward a common goal. J Natl Compr Canc Netw 18:366–369. doi:10.6004/jnccn.2020.7560.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Lieberman JA,
    2. Pepper G,
    3. Naccache SN,
    4. Huang M-L,
    5. Jerome KR,
    6. Greninger AL
    . 2020. Comparison of commercially available and laboratory developed assays for in vitro detection of SARS-CoV-2 in clinical laboratories. J Clin Microbiol doi:10.1128/JCM.00821-20.
    OpenUrlCrossRef
  5. 5.↵
    1. Randhawa AK,
    2. Fisher LH,
    3. Greninger AL,
    4. Li SS,
    5. Andriesen J,
    6. Corey L,
    7. Jerome KR
    . 2020. Changes in SARS-CoV-2 positivity rate in outpatients in Seattle and Washington State, March 1-April 16, 2020. JAMA doi:10.1001/jama.2020.8097.
    OpenUrlCrossRef
  6. 6.↵
    1. Sutton D,
    2. Fuchs K,
    3. D'Alton M,
    4. Goffman D
    . 2020. Universal screening for SARS-CoV-2 in women admitted for delivery. N Engl J Med 382:2163–2164. doi:10.1056/NEJMc2009316.
    OpenUrlCrossRefPubMed
  7. 7.↵
    Greater Seattle Coronavirus Assessment Network. 2020. SCAN technical report. Greater Seattle Coronavirus Assessment Network, Seattle, WA. https://publichealthinsider.com/wp-content/uploads/2020/04/SCAN-Technical-Report-v1-17-APR-2020.pdf. Accessed 23 April 2020.
PreviousNext
Back to top
Download PDF
Citation Tools
Preprocedural Surveillance Testing for SARS-CoV-2 in an Asymptomatic Population in the Seattle Region Shows Low Rates of Positivity
James A. Mays, Alexander L. Greninger, Keith R. Jerome, John B. Lynch, Patrick C. Mathias
Journal of Clinical Microbiology Jul 2020, 58 (8) e01193-20; DOI: 10.1128/JCM.01193-20

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Preprocedural Surveillance Testing for SARS-CoV-2 in an Asymptomatic Population in the Seattle Region Shows Low Rates of Positivity
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Preprocedural Surveillance Testing for SARS-CoV-2 in an Asymptomatic Population in the Seattle Region Shows Low Rates of Positivity
James A. Mays, Alexander L. Greninger, Keith R. Jerome, John B. Lynch, Patrick C. Mathias
Journal of Clinical Microbiology Jul 2020, 58 (8) e01193-20; DOI: 10.1128/JCM.01193-20
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • LETTER
    • ACKNOWLEDGMENTS
    • REFERENCES
  • Info & Metrics
  • PDF

KEYWORDS

COVID-19
procedures
SARS-CoV-2
surveillance

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X